[Hypofractionated stereotactic radiotherapy of bone metastases]

Abstract : Hypofractionated stereotactic radiotherapy can deliver high doses of bone metastases while sparing adjacent healthy tissue not only for a decompressive or analgesic purpose, but also to improve the local control of the irradiated region. Various phases I or II studies showed the feasibility of such an approach at the cost of limited toxicity, including during re-irradiation. Hypofractionated stereotactic radiotherapy to oligometastases may also improve the long-term control of metastatic disease.
Type de document :
Article dans une revue
Liste complète des métadonnées

Contributeur : Cécile Nowak <>
Soumis le : vendredi 28 juin 2019 - 13:49:16
Dernière modification le : samedi 29 juin 2019 - 01:34:56



B. Pichon, F. Thillays, Céline Bourgier, M. A. Mahe, S. Supiot. [Hypofractionated stereotactic radiotherapy of bone metastases]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014, 18, pp.342--9. ⟨10.1016/j.canrad.2014.04.005⟩. ⟨hal-02168047⟩



Consultations de la notice